Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AJANTA PHARMA vs GSK PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AJANTA PHARMA GSK PHARMA AJANTA PHARMA/
GSK PHARMA
 
P/E (TTM) x 23.4 57.5 40.8% View Chart
P/BV x 4.8 8.5 57.0% View Chart
Dividend Yield % 0.8 6.7 11.4%  

Financials

 AJANTA PHARMA   GSK PHARMA
EQUITY SHARE DATA
    AJANTA PHARMA
Mar-22
GSK PHARMA
Mar-22
AJANTA PHARMA/
GSK PHARMA
5-Yr Chart
Click to enlarge
High Rs1,6141,917 84.2%   
Low Rs1,0891,400 77.8%   
Sales per share (Unadj.) Rs391.1193.5 202.1%  
Earnings per share (Unadj.) Rs83.422.5 371.2%  
Cash flow per share (Unadj.) Rs98.126.5 370.2%  
Dividends per share (Unadj.) Rs9.5090.00 10.6%  
Avg Dividend yield %0.75.4 13.0%  
Book value per share (Unadj.) Rs382.1157.2 243.1%  
Shares outstanding (eoy) m85.42169.41 50.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.58.6 40.3%   
Avg P/E ratio x16.273.8 22.0%  
P/CF ratio (eoy) x13.862.6 22.0%  
Price / Book Value ratio x3.510.6 33.5%  
Dividend payout %11.4400.4 2.8%   
Avg Mkt Cap Rs m115,433280,960 41.1%   
No. of employees `000NANA-   
Total wages/salary Rs m6,4586,102 105.8%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m33,41032,780 101.9%  
Other income Rs m1,157758 152.7%   
Total revenues Rs m34,56733,538 103.1%   
Gross profit Rs m9,2937,735 120.1%  
Depreciation Rs m1,253682 183.7%   
Interest Rs m10220 511.0%   
Profit before tax Rs m9,0957,790 116.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,9683,983 49.4%   
Profit after tax Rs m7,1273,808 187.2%  
Gross profit margin %27.823.6 117.9%  
Effective tax rate %21.651.1 42.3%   
Net profit margin %21.311.6 183.6%  
BALANCE SHEET DATA
Current assets Rs m24,54837,080 66.2%   
Current liabilities Rs m8,37716,984 49.3%   
Net working cap to sales %48.461.3 79.0%  
Current ratio x2.92.2 134.2%  
Inventory Days Days4291 45.9%  
Debtors Days Days11229 4.9%  
Net fixed assets Rs m19,2598,121 237.2%   
Share capital Rs m1721,694 10.1%   
"Free" reserves Rs m32,46924,936 130.2%   
Net worth Rs m32,64026,630 122.6%   
Long term debt Rs m160-   
Total assets Rs m43,80745,201 96.9%  
Interest coverage x90.2391.3 23.0%   
Debt to equity ratio x00-  
Sales to assets ratio x0.80.7 105.2%   
Return on assets %16.58.5 194.9%  
Return on equity %21.814.3 152.7%  
Return on capital %28.229.3 96.0%  
Exports to sales %00-   
Imports to sales %027.0 0.0%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNA8,853 0.0%   
Fx inflow Rs m18,678528 3,539.0%   
Fx outflow Rs m3,6628,853 41.4%   
Net fx Rs m15,016-8,325 -180.4%   
CASH FLOW
From Operations Rs m5,6208,107 69.3%  
From Investments Rs m-741-4,055 18.3%  
From Financial Activity Rs m-4,600-5,242 87.8%  
Net Cashflow Rs m279-1,190 -23.4%  

Share Holding

Indian Promoters % 70.5 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 21.4 12.7 168.1%  
FIIs % 8.2 2.2 379.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.5 25.0 118.1%  
Shareholders   62,048 116,651 53.2%  
Pledged promoter(s) holding % 17.4 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AJANTA PHARMA With:   SUN PHARMA    DR. REDDYS LAB    CIPLA    LUPIN    ZYDUS LIFESCIENCES    


More on AJANTA PHARMA vs GSK Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

AJANTA PHARMA vs GSK Pharma Share Price Performance

Period AJANTA PHARMA GSK Pharma S&P BSE HEALTHCARE
1-Day -0.47% -0.38% -0.89%
1-Month -1.42% -0.27% -1.85%
1-Year -11.79% -27.63% -6.83%
3-Year CAGR 23.19% -6.16% 20.56%
5-Year CAGR 5.07% -11.52% 10.73%

* Compound Annual Growth Rate

Here are more details on the AJANTA PHARMA share price and the GSK Pharma share price.

Moving on to shareholding structures...

The promoters of AJANTA PHARMA hold a 70.5% stake in the company. In case of GSK Pharma the stake stands at 75.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of AJANTA PHARMA and the shareholding pattern of GSK Pharma.

Finally, a word on dividends...

In the most recent financial year, AJANTA PHARMA paid a dividend of Rs 9.5 per share. This amounted to a Dividend Payout ratio of 11.4%.

GSK Pharma paid Rs 90.0, and its dividend payout ratio stood at 400.4%.

You may visit here to review the dividend history of AJANTA PHARMA, and the dividend history of GSK Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Snaps 4-Day Losing Streak, Gains 160 Points | Bank Nifty Gains 1% to Hit Record High | PSU Bank Stocks Rally(Closing)

After opening the day on a flat note, Indian share markets extended gains during the last hour of trade to end higher.